69 results
IDSA Aspergillosis Treatment
 • Invasive pulmonary aspergillosis (IPA)
 • CNS aspergillosis
 • Cardiac Aspergillus infection
 •
IDSA Aspergillosis ... Treatment • Invasive ... Aspergillosis #Treatment ... #management #pharmacology ... #IDSA
IDSA Treatment of Necrotizing Infections of the Skin, Fascia, and Muscle
 • Mixed infections
 • Streptococcus
IDSA Treatment of ... fasciitis #Skin #IDSA ... #Treatment #management ... #antibiotics #pharmacology
Parenteral Antimicrobial Treatment of Common Microorganisms Causing Native Vertebral Osteomyelitis - IDSA 
Staphylococci, oxacillin susceptible
Staphylococci, oxacillin
Antimicrobial Treatment ... Osteomyelitis - IDSA ... Osteomyelitis #management ... #treatment #pharmacology ... #idsa
IDSA - Doses of Drugs for Treatment of Adults and Children with Multidrug-Resistant Tuberculosis
Step 1 Levofloxacin,
IDSA - Doses of ... Drugs for Treatment ... Tuberculosis #MDRTB #management ... #pharmacology # ... dosing #idsa #drugs
Outpatient Treatment of with Community-Acquired Pneumonia (CAP)
No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
Outpatient Treatment ... fluoroquinolone #IDSA ... #Antibiotics #Treatment ... #Regimen #Management ... #Guidelines #pharmacology
Asymptomatic Bacteriuria - IDSA Indications for Treatment
Healthy non-pregnant women - NO
Healthy pregnant women - YES
Functionally impaired
Bacteriuria - IDSA ... Indications for Treatment ... community or long-term care ... #Bacteriuria #IDSA ... #management #UTI
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
IDSA Recommendations ... Disease Note: Treatment ... Trypanosomiasis #IDSA ... #management #opportunistic ... infections #HIVAIDS #pharmacology
Sexually Transmitted Infections - Common Outpatient Treatments 
Chlamydia 
 - Azithromycin 1 g PO once
Common Outpatient Treatments ... of ambulatory care ... the first-line treatments ... STIs #Outpatient #Treatment ... #Management #Pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... Systemic antifungals are ... candida #mucosal #IDSA ... #management #opportunistic ... infections #HIVAIDS #pharmacology
COVID-19 review…here is a list of some of the drugs that are currently being used or
the drugs that are ... most effective treatments ... #CoronaVirus #Treatment ... #Management #Pandemic ... Pharmacotherapy #Pharmacology